'I'm amazed i've been able to come off injections': Patient's perceptions of genetic testing in diabetes: Report of the Janet Kinson Lecture, Diabetes UK 2003

Practical Diabetes International

Volumn 20, Issue 9, 2003, Pages 338-342

  Shepherd, Maggie ^a  

^a PENINSULA MEDICAL SCHOOL   (United Kingdom)

Author keywords

Genetic testing; Hepatocyte nuclear factor 1 alpha; Maturity onset diabetes of the young; Sulphonylurea sensitivity

Indexed keywords

GLICLAZIDE; INSULIN; NEUTRAL INSULIN; NUCLEAR FACTOR I; NUCLEAR FACTOR I ALPHA; SULFONYLUREA DERIVATIVE; UNCLASSIFIED DRUG;

BLOOD GLUCOSE MONITORING; CONFERENCE PAPER; DETERIORATION; DIABETES CONTROL; DIAGNOSTIC ERROR; DRUG EFFECT; DRUG SAFETY; DRUG SENSITIVITY; DRUG WITHDRAWAL; GENE IDENTIFICATION; GENE MUTATION; GENETIC SCREENING; GENETICS; HEALTH CARE PERSONNEL; HEMOGLOBIN DETERMINATION; HUMAN; HUMAN RELATION; INHERITANCE; INJECTION; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN HYPOGLYCEMIA; INTERVIEW; LIFESTYLE; MATURITY ONSET DIABETES MELLITUS; PANCREAS ISLET TRANSPLANTATION; PATIENT ATTITUDE; QUALITATIVE ANALYSIS; SELF CONCEPT; SHORT COURSE THERAPY; TABLET;

EID: 0344665736     PISSN: 13578170     EISSN: None     Source Type: Journal    
DOI: 10.1002/pdi.555     Document Type: Conference Paper

References (15)

1. Stride A, Hattersley AT. Different genes, different diabetes: Lessons from maturity-onset diabetes of the young. Ann Med 2002; 34(3): 207-216.
2. Hathout EH, Cockburn BN, Mace JW, et al. A case of hepatocyte nuclear factor-1 alpha diabetes/MODY 3 masquerading as type 1 diabetes in a Mexican American adolescent and responsive to a low dose of sulphonylurea. Diabetes Care 1999; 22(5): 867-868.
3. Møller AM, Dalgaard LT, Pociot F, et al. Mutations in the hepatocyte nuclear factor-1 alpha gene in Caucasian families originally classified as having Type 1 diabetes. Diabetologia 1998; 41(12): 1528-1531.
4. Shepherd M. Genetic testing in maturity onset diabetes of the young (MODY) - Practical guidelines for professionals. Pract Diabetes Int 2003; 20(3): 108-110.
5. Frayling TM, Bulman MP, Ellard S, et al. Mutations in the hepatocyte nuclear factor-1 alpha gene are a common cause of maturity-onset diabetes of the young in the U.K. Diabetes 1997; 46(4): 720-725.
6. Shepherd M, Hattersley AT, Sparkes AC. Lay beliefs about maturity onset diabetes of the young. J Diabetes Nursing 2000; 4(5): 140-143.
7. Pearson ER, Starkey BJ, Powell RJ, et al. Genetic cause of hyperglycaemia and response to treatment in diabetes. Lancet 2003; 362(9392): 1275-1281.
8. Lambert AP, Ellard S, Allen LI, et al. Identifying hepatic nuclear factor 1 alpha mutations in children and young adults with a clinical diagnosis of type 1 diabetes. Diabetes Care 2003; 26(2): 333-337.
9. Shepherd M, Hattersley AT, Sparkes AC. Predictive genetic testing in diabetes: A case study of multiple perspectives. Qualitative Health Research 2000; 10(2): 242-259.
10. Thorne S, Nyhlin KT, Paterson BL. Attitudes toward patient expertise in chronic illness. Int J Nursing Studies 2000; 37: 303-311.
11. Sheperd M, Pearson ER, Salt G, et al. No deterioration in glycaemic control in HNF1 alpha MODY following transfer from long term insulin to sulphonylureas. Diabetes Care 2003; 26(1): 3191-3192.
12. Shepherd M. 'I don't feel like a diabetic anymore': The impact of stopping insulin in HNF-1 alpha MODY. Clin Med (in press).
13. Shepherd M, Houghton J. An educational model for the integration of genetics into diabetes care. Pract Diabetes Int 2002; 19(8): 244.
14. Shepherd M, Stride A, Ellard S, et al. Integrating genetics into diabetes care: A new role for DSNs. J Diabetes Nursing 2003; 7(8): 289-292.
15. Shapiro AM, Lakey JR, Ryan EA, et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 2000; 343(4): 230-238.